GN Store Nord A/S GN.CO
Nasdaq Copenhagen · Healthcare · Medical Devices
123.65 DKK
−0.3%
2026-11-06
Keep this stock on your watchlist and set email alerts for prices, reports and important announcements where available.
Annual accounts for GN Store Nord
| DKK million | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | 18,687 | 18,120 | 17,985 | 16,782 |
| EBITDA | 2,445 | 2,398 | 3,119 | 2,646 |
| Net income | 511 | 228 | 988 | 653 |
| Balance sheet | ||||
| Equity | 6,800 | 9,587 | 10,824 | 10,898 |
| Total debt | 16,253 | 13,499 | 11,487 | 10,815 |
| Cash | 990 | 2,162 | 980 | 1,119 |
| Net debt | 15,263 | 11,337 | 10,507 | 9,696 |
| Ratios and per share | ||||
| EBITDA margin | 13.1% | 13.2% | 17.3% | 15.8% |
| Profit margin | 2.7% | 1.3% | 5.5% | 3.9% |
| Return on equity | 7.5% | 2.4% | 9.1% | 6.0% |
| Earnings/share (DKK) | 3.99 | 1.57 | 6.79 | 4.48 |
| Book value/share (DKK) | 53.14 | 65.84 | 74.33 | 74.84 |
| Shares outstanding (M) | 128 | 146 | 146 | 146 |
From the annual statements (Yahoo Finance), in the currency the company reports in. Per-share figures use the shares at the year end. Charts and annual figures →
Key figures
| P/E | 27.6 |
| P/B | 1.7 |
| EV / EBITDA | 10.5 |
| Net debt / EBITDA | 3.7 |
| Return on equity | 6.0% |
| Profit margin | 3.9% |
| Beta 1Y | 1.01 |
| Revenue growth 1Y | −6.7% |
| Revenue CAGR 3Y | −3.5% |
| Earnings/share CAGR 3Y | +3.9% |
| ROE avg. 3Y | 5.8% |
Ratios use the latest annual report that was public 90 days after the year end.
Dividends per share (DKK)
| 2022 | 1.55 |
Not investment advice. Figures may contain errors from the data source.